Clinical Trial

A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.

Recruiting
View on ClinicalTrials.gov →
Summary
To confirm the effectiveness and safety of the GeminiOne Transcatheter Mitral Valve Repair System for the treatment of severe, symptomatic mitral regurgitation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-22.
Status change: Not Yet Recruiting → Recruiting 2026-04-21
Trial Details
NCT Number NCT07086534
Lead Sponsor Sierra Valve LLC
Conditions Mitral Regurgitation
Enrollment 15 participants
Start Date 2026-03-26
Primary Completion 2027-04-30 (estimated)
Study Completion 2031-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24